MONTELUKAST SODIUM (MONTELUKAST SODIUM) — FDA Approval ANDA207463 (CIPLA)
MONTELUKAST SODIUM (MONTELUKAST SODIUM) — FDA Approval ANDA207463 (CIPLA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: MONTELUKAST SODIUM; Active ingredients: MONTELUKAST SODIUM; Application number: ANDA207463.
| Brand name | MONTELUKAST SODIUM |
|---|---|
| Active ingredients | MONTELUKAST SODIUM |
| Application number | ANDA207463 |
| Sponsor | CIPLA |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20161028 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →